A recent study showed that miR-497 negatively regulated glioma cells by targeting oncogene Wnt3α and that reduced expression of miR-497 was associated with poor disease-free and overall survival rates (Lu et al., 2018). Here, WNT3A is linked to central nervous system cancer.